Press Releases

Cambridge Cognition, a leader in digital health solutions for brain health assessment, has announced the appointments of Alex Livingstone-Learmonth as Chief Commercial Officer and Annabelle Miles as Head of Marketing. These strategic additions mark a significant step as the Company continues strengthening its senior leadership team in pursuit of its ambitious growth strategy. 

Alex joins Cambridge Cognition with a wealth of sector experience, having worked in the clinical trial technology, services and solutions industry for over 20 years. Having previously held the role of Vice President at Calyx and Signant Health (initially CRF Health), Alex’s background complements Cambridge Cognition’s commercial model and his experience in promoting clinical trial solutions will be instrumental as the Group continues to focus on delivering profitable growth.

Annabelle Miles started her career at M&C Saatchi and McCann Worldwide, accumulating over 10 years of experience in advertising and marketing. During her tenure at FUNDAMENTALVR, a health VR start-up, she established a comprehensive marketing function over five years. Her most recent position at Huma involved spearheading a results-driven lead-generation strategy for marketing healthcare solutions and clinical trials.  

Alex and Annabelle will play vital roles in supporting the Company’s growth strategy, implementing processes to build the orderbook, increasing awareness and brand exposure for our market leading offering and technology.  

Matthew Stork, Chief Executive Officer of Cambridge Cognition, commented:

“At this critical phase in our growth trajectory, I am delighted to welcome Alex and Annabelle to the business. Both have significant sector experience, and I am confident they will provide valuable expertise in their roles as we continue to drive growth.”

Alex Livingstone-Learmonth, incoming Chief Commercial Officer of Cambridge Cognition, commented:

 “I’m delighted to join Cambridge Cognition and leverage my industry experience to help the team deliver its next phase of growth. This is an exciting business, with amazing potential – especially when looking at our core three products; cognitive assessments, eCOA and our automated quality assurance tool.”

Annabelle Miles, incoming Head of Marketing of Cambridge Cognition, commented: 

“I am thrilled to have been appointed as Head of Marketing for Cambridge Cognition. I am passionate about health-tech and Cambridge Cognition’s proposition and commitment to providing digital solutions to assess brain health. I look forward to supporting the team as we do our upmost to drive sales to deliver against the Company’s significant growth potential.”

About Cambridge Cognition

Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.

For further information visit www.cambridgecognition.com